期刊文献+

影响慢性阻塞性肺疾病急性加重患者住院病死率的危险因素 被引量:32

Risk factors for in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨影响慢性阻塞性肺疾病急性加重(AECOPD)患者住院期间病死率的危险因素。方法回顾性分析南方医院呼吸与危重症医学科2010年1月至2012年8月因AECOPD住院治疗的182例患者的临床资料。搜集和分析患者一般资料、稳定期情况、肺功能、血常规、血气分析、C反应蛋白(CRP)等指标,对影响患者预后的危险因素进行Logistic多因素回归分析。结果182例患者中死亡42例,好转140例。死亡组患者中稳定期综合评估急性加重风险高、低外周血淋巴细胞计数、高CRP、合并贫血、低蛋白血症、高碳酸血症、慢性肺源性心脏病、缺血性心脏病方面的所占比例分别为90.4%、73.8%、50.O%、50.0%、71.4%、64.3%、76.1%、19.0%,好转组分别为70.0%、47.1%、17.1%、27.1%、46.4%、30.7%、40.7%、7.O%,组间差异均有统计学意义(均P〈0.05)。高CRP(OR=3.226,P=0.009)、高碳酸血症(OR=2.928,P=0.013)、慢性肺源性心脏病(OR=2.510,P=0.045)、低外周血淋巴细胞计数(OR=2.488,P=0.045)是影响AECOPD患者住院期间死亡的独立危险因素。结论低外周血淋巴细胞、高CRP、高碳酸血症、慢性肺源性心脏病是影响AECOPD患者住院期间死亡的独立危险因素。 Objective To explore the risk factors for hospitalization case fatality of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A retrospective review of medical records was performed for 182 hospitalized AECOPD patients at Nanfang Hospital from January 2010 to August 2012. Their general information, condition in stable stage, the results of spirometry, blood routine test, blood gas analysis and C-reactive protein (CRP) were collected and analyzed. The risk factors for mortality were analyzed by muhivariable Logistic regression. Results Among them, 42 died during hospitalization. Univariate analysis revealed that 8 factors had significant differences between two groups ( all P 〈 0. 05 ) : high exacerbation risk ( death vs improvement group, 90. 4% vs 70. 0% ) , low peripheral absolute lymphocyte count (73.8% vs 47. 1% ) , high CRP (50. 0% vs 17.1% ) , concurrent anemia (50. 0% vs 27.1% ), hypoproteinemia (71.4% vs 46.4% ), hypereapnia (64. 3% vs 30. 7% ), chronic pulmonary heart disease (76. 1% vs 40. 7% ) and ischemic heart disease (19.0% vs 7.0% ). By multiple Logistic regression analysis, high CRP ( OR = 3. 226, P = 0. 009 ) , hypereapnia ( OR = 2. 928, P = 0. 013 ), chronic pulmonary heart disease ( OR = 2. 510, P = 0. 045 ) , low peripheral absolute lymphocyte count (OR = 2. 488, P = 0. 045 ) were the independent risk factors for hospitalization case fatality of AECOPD patients. Conclusion Low peripheral absolute lymphocyte count, high CRP, hypercapnia and chronic pulmonary heart disease were the independent risk factors for mortality in hospitalized AECOPD patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第18期1374-1377,共4页 National Medical Journal of China
基金 国家自然科学基金(81270087、81270089) 国家重点基础研究发展计划(973计划)(2012CB518203)
关键词 肺疾病 慢性阻塞性 死亡率 危险因素 疾病严重程度 Pulmonary disease, chronic obstructive Mortality L Risk factors Severity of illness
  • 相关文献

参考文献12

  • 1Rabe KF, Hurd S, Anzueto A, et al. Global strategy for thediagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007, 176: 532-555.
  • 2Slenter RH, Sprooten RT, Kotz D, et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration, 2013, 85: 15-26.
  • 3Fruehter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology, 2008, 13 : 851-855.
  • 4Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration, 2012,84: 17-26.
  • 5Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med, 2013, 187 : 347-365.
  • 6Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Researh Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive disease. Thorax, 1999, 54: 581-586.
  • 7Alfageme I, Reyes N, Merino M, et al. The effect of airflow limitation on the cause of death in patients with COPD. Chron Respir Dis, 2010, 7: 135-145.
  • 8Ko FW, Ip M, Chan PK, et al. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia. Respir Med, 2008, 102: 1109-1116.
  • 9Antonescu-Turcu AL, Tomie R. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Curr ODin Pulm Med. 200q 15. 170-19:;.
  • 10常春,姚婉贞,方天舒.慢性阻塞性肺疾病患者死因构成及其生存时间的影响因素[J].中华医学杂志,2011,91(12):824-827. 被引量:27

二级参考文献15

  • 1谢俊刚,徐永健.国内外COPD流行病学进展[J].中国实用内科杂志:临床前沿版,2006,26(9):1401-1403. 被引量:33
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 3Lopez AD,Shibuya K,Rao C,et al.Chronic obstructive pulmonary disease:current burden and future projections.Eur Respir J,2006,27:397-412.
  • 4McGarvey LP,John M,Anderson JA,et al.Ascertainment of cause-specific mortality in COPD:operations of the TORCH Clinical Endpoint Committee.Thorax,2007,62:411-415.
  • 5Charlson ME,Pompei P,Ales KL,et al.A new method of classifying prognostic comorbidity in longitudinal studies:development and validation.J Chronic Dis,1987,40:373-383.
  • 6Sundararajan V,Henderson T,Perry C,et al.New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality.J Clin Epidemiol,2004,57:1288-1294.
  • 7Rodríguez-Roisin R,Soriano JB.Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease.Proc Am Thorac Soc,2008,5:842-847.
  • 8Hansell AL,Walk JA,Soriano JB.What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis.Eur Respir J,2003,22:809-814.
  • 9Calverley PM,Anderson JA,Celli B,et al.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.N Engl J Med,2007,356:775-789.
  • 10Sin DD,Anthonisen NR,Soriano JB,et al.Mortality in COPD:Role of comorbidities.Eur Respir J,2006,28:1245-1257.

共引文献26

同被引文献256

引证文献32

二级引证文献324

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部